Supplemental folic acid in pregnancy and childhood cancer risk

Jan Helge Seglem Mortensen, Nina Øyen, Tatiana Fomina, Mads Melbye, Steinar Tretli, Stein Emil Vollset, Tone Bjørge*

*Corresponding author af dette arbejde
16 Citationer (Scopus)

Abstract

Background:We investigated the association between supplemental folic acid in pregnancy and childhood cancer in a nation-wide study of 687 406 live births in Norway, 1999-2010, and 799 children diagnosed later with cancer.Methods:Adjusted hazard ratios (HRs) compared cancer risk in children by approximated periconceptional folic acid levels (folic acid tablets and multivitamins (0.6 mg), only folic acid (0.4 mg), only multivitamins (0.2 mg)) and cancer risk in unexposed.Results:Any folic acid levels were not associated with leukemia (e.g., high-level folic acid HR 1.25; 95% CI 0.89-1.76, P Trend 0.20), lymphoma (HR 0.96; 95% CI 0.42-2.21, P Trend 0.51), central nervous system tumours (HR 0.68; 95% CI 0.42-1.10, P Trend 0.32), neuroblastoma (HR 1.05; 95% CI 0.53-2.06, P Trend 0.85), Wilms' tumour (HR 1.16; 95% CI 0.52-2.58, P Trend 0.76), or soft-tissue tumours (HR 0.77; 95% CI 0.34-1.75, P Trend 0.90).Conclusions:Folic acid supplementation was not associated with risk of major childhood cancers.

OriginalsprogEngelsk
TidsskriftBritish Journal of Cancer
Vol/bind114
Sider (fra-til)71-75
Antal sider5
ISSN0007-0920
DOI
StatusUdgivet - 2016

Fingeraftryk

Dyk ned i forskningsemnerne om 'Supplemental folic acid in pregnancy and childhood cancer risk'. Sammen danner de et unikt fingeraftryk.

Citationsformater